New Atmosphere, New Vision: Gibson and Whittemore Kick Off Invest in ME Conference 2016
Mark Berry reports on Dr. Gibson's introduction and Dr. Whittemore's keynote speech, at the 11th Invest in ME International ME Conference in London.
Discuss the article on the Forums.

PGC-1alpha and TFEB provide two new therapeutic targets for Huntington's disease

Discussion in 'Other Health News and Research' started by Marco, Aug 13, 2012.

  1. Marco

    Marco Grrrrrrr!

    Messages:
    2,179
    Likes:
    2,422
    Near Cognac, France
    I've posted before on the potential importance of the mitochondria stimulating PGC1-alpha pathway before in general bio-energetics terms. Not so much from the perspective of neuroprotection.

    Its importance may go well beyond 'fatigue' and exercise tolerance :


    My bold.

    http://www.news-medical.net/news/20...rapeutic-targets-for-Huntingtons-disease.aspx
     

See more popular forum discussions.

Share This Page